Long-term survival in a patient with advanced lung adenocarcinoma harboring synchronous EGFR exon 18 G719A and BRAF V600E mutations and treated with afatinib
Keyword(s):
Keyword(s):
2018 ◽
Vol 10
(4)
◽
pp. 2070-2078
◽
Keyword(s):